Compounds > temoporfin
Page last updated: 2024-08-24

temoporfin and Carcinoma, Hepatocellular

temoporfin has been researched along with Carcinoma, Hepatocellular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Kader, MH; Abdelaziz, AI; Elsayed, OF; Rueck, A; Saad Zaghloul, MA; Sherifa, G; Steiner, R1
Kessel, D1

Other Studies

2 other study(ies) available for temoporfin and Carcinoma, Hepatocellular

ArticleYear
Functional characterization of Fospeg, and its impact on cell cycle upon PDT of Huh7 hepatocellular carcinoma cell model.
    Photodiagnosis and photodynamic therapy, 2013, Volume: 10, Issue:1

    Topics: Animals; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Liver Neoplasms; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents

2013
Inhibition of endocytic processes by photodynamic therapy.
    Lasers in surgery and medicine, 2011, Volume: 43, Issue:7

    Topics: Androstadienes; Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Endocytosis; Epithelial Cells; Humans; Indoles; Leukemia; Liver Neoplasms; Mesoporphyrins; Mice; Models, Biological; Organelles; Organometallic Compounds; Phosphodiesterase Inhibitors; Photochemotherapy; Photosensitizing Agents; Porphyrins; Wortmannin

2011